Tuesday, May 4, 2010
Hmmm
Antibiotics for irritable bowel syndrome? I suppose the biological plausibility argument would be that IBS is a result either of bacterial overgrowth or of an as-yet-unidentified pathogen that is responsive to rifaximin. I haven't been following this literature at all, but my understanding is that other antibiotic trials have not been fruitful (at least for long term alleviation of symptoms), so before I run with an abstract about a study funded by the makers of the drug, I'd like to see more data--starting with the results of this trial being published in a peer-reviewed journal.
Subscribe to:
Post Comments (Atom)
OSHA! OSHA! OSHA!
In many parts of the country, as rates of COVID-19 are declining and vaccination coverage is increasing (albeit with substantial variati...
-
In many parts of the country, as rates of COVID-19 are declining and vaccination coverage is increasing (albeit with substantial variati... -
This is a guest post by Jorge Salinas, MD, Hospital Epidemiologist at the University of Iowa Hospitals & Clinics. There is virtually no...
-
I’m surprised that we can’t stop arguing about the modes of SARS-CoV-2 transmission, despite the fact that most experts (including our frie...
No comments:
Post a Comment
Thanks for submitting your comment to the Controversies blog. To reduce spam, all comments will be reviewed by the blog moderator prior to publishing. However, all legitimate comments will be published, whether they agree with or oppose the content of the post.